Cumulative Lifetime Marijuana Use and Incident Cardiovascular Disease in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
- PMID: 28207342
- PMCID: PMC5343712
- DOI: 10.2105/AJPH.2017.303654
Cumulative Lifetime Marijuana Use and Incident Cardiovascular Disease in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
Abstract
Objectives: To investigate the effects of marijuana in the development of incident cardiovascular and cerebrovascular outcomes.
Methods: Participants were 5113 adults aged 18 to 30 years at baseline (1985-1986) from the Coronary Artery Risk Development in Young Adults study, who were followed for more than 25 years. We estimated cumulative lifetime exposure to marijuana using repeated assessments collected at examinations every 2 to 5 years. The primary outcome was incident cardiovascular disease (CVD) through 2013.
Results: A total of 84% (n = 4286) reported a history of marijuana use. During a median 26.9 years (131 990 person-years), we identified 215 CVD events, including 62 strokes or transient ischemic attacks, 104 cases of coronary heart disease, and 50 CVD deaths. Compared with no marijuana use, cumulative lifetime and recent marijuana use showed no association with incident CVD, stroke or transient ischemic attacks, coronary heart disease, or CVD mortality. Marijuana use was not associated with CVD when stratified by age, gender, race, or family history of CVD.
Conclusions: Neither cumulative lifetime nor recent use of marijuana is associated with the incidence of CVD in middle age.
Comment in
-
Investigating Cumulative Marijuana Use and Risk of Cardiovascular Disease in Middle Age With Longitudinal Data.Am J Public Health. 2018 Apr;108(4):e11-e12. doi: 10.2105/AJPH.2018.304307. Am J Public Health. 2018. PMID: 29513575 Free PMC article. No abstract available.
-
Reis et al. Respond.Am J Public Health. 2018 Apr;108(4):e12. doi: 10.2105/AJPH.2018.304308. Am J Public Health. 2018. PMID: 29513576 Free PMC article. No abstract available.
References
-
- Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE. National Survey Results on Drug Use: 1975–2014. 2015 Overview: Key Findings on Adolescent Drug Use. Ann Arbor, MI: Institute for Social Research, the University of Michigan; 2015. Monitoring the Future.
-
- Benowitz NL, Rosenberg J, Rogers W, Bachman J, Jones RT. Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms. Clin Pharmacol Ther. 1979;25(4):440–446. - PubMed
-
- Beaconsfield P, Ginsburg J, Rainsbury R. Marihuana smoking. Cardiovascular effects in man and possible mechanisms. N Engl J Med. 1972;287(5):209–212. - PubMed
-
- Merritt JC, Cook CE, Davis KH. Orthostatic hypotension after delta 9-tetrahydrocannabinol marihuana inhalation. Ophthalmic Res. 1982;14(2):124–128. - PubMed
-
- Benowitz NL, Jones RT. Cardiovascular and metabolic considerations in prolonged cannabinoid administration in man. J Clin Pharmacol. 1981;21(8–9 suppl):214S–223S. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources